Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemiaVijay Sagar Madamsetty, Asher Chanan‐Khan, Sharoon Akhtar et al.|Leukemia & lymphoma/Leukemia and lymphoma|2020Cited by 6